Liquid biopsies: the future of cancer early detection
S Connal, JM Cameron, A Sala, PM Brennan… - Journal of translational …, 2023 - Springer
Cancer is a worldwide pandemic. The burden it imposes grows steadily on a global scale
causing emotional, physical, and financial strains on individuals, families, and health care …
causing emotional, physical, and financial strains on individuals, families, and health care …
The updated role of exosomal proteins in the diagnosis, prognosis, and treatment of cancer
X Wang, J Huang, W Chen, G Li, Z Li… - Experimental & molecular …, 2022 - nature.com
Exosomes are vesicles encompassed by a lipid bilayer that are released by various living
cells. Exosomal proteins are encapsulated within the membrane or embedded on the …
cells. Exosomal proteins are encapsulated within the membrane or embedded on the …
Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆
A González-Martín, P Harter, A Leary… - Annals of …, 2023 - annalsofoncology.org
Epithelial ovarian cancer (EOC) represents a heterogeneous spectrum of disease entities at
a clinical, pathological and molecular level. Ovarian cancer is the second most lethal …
a clinical, pathological and molecular level. Ovarian cancer is the second most lethal …
Simultaneous detection of ovarian cancer-concerned HE4 and CA125 markers based on Cu single-atom-triggered CdS QDs and Eu MOF@ Isoluminol ECL
Y Tang, Y Liu, Y Xia, F Zhao, B Zeng - Analytical Chemistry, 2023 - ACS Publications
Simultaneous detection of different disease markers is significant for clinical diagnosis. In
this work, a dual-signal electrochemiluminescence (ECL) immunosensor was constructed …
this work, a dual-signal electrochemiluminescence (ECL) immunosensor was constructed …
Early-stage multi-cancer detection using an extracellular vesicle protein-based blood test
JP Hinestrosa, R Kurzrock, JM Lewis… - Communications …, 2022 - nature.com
Background Detecting cancer at early stages significantly increases patient survival rates.
Because lethal solid tumors often produce few symptoms before progressing to advanced …
Because lethal solid tumors often produce few symptoms before progressing to advanced …
The challenges and prospects of p53-based therapies in ovarian cancer
B Wallis, KR Bowman, P Lu, CS Lim - Biomolecules, 2023 - mdpi.com
It has been well established that mutations in the tumor suppressor gene, p53, occur readily
in a vast majority of cancer tumors, including ovarian cancer. Typically diagnosed in stages …
in a vast majority of cancer tumors, including ovarian cancer. Typically diagnosed in stages …
Gemcitabine cationic polymeric nanoparticles against ovarian cancer: formulation, characterization, and targeted drug delivery
This study focused on gemcitabine (GTB) delivery of cationic polymeric nanoparticles to treat
ovarian cancer in order to promote effective localized delivery and drug retention during …
ovarian cancer in order to promote effective localized delivery and drug retention during …
Hormonal therapy for gynecological cancers: how far has science progressed toward clinical applications?
Simple Summary The most common therapies for severe and recurrent gynecological
cancers are hormone therapy and chemotherapy, and responsiveness to therapy is a key …
cancers are hormone therapy and chemotherapy, and responsiveness to therapy is a key …
Emerging targeted drug delivery strategies toward ovarian cancer
Ovarian cancer is a high-mortality malignancy in women. The contemporary clinical
chemotherapy with classic cytotoxic drugs, targeted molecular inhibitors would mostly fail …
chemotherapy with classic cytotoxic drugs, targeted molecular inhibitors would mostly fail …
Carbon-based biosensors from graphene family to carbon dots: A viewpoint in cancer detection
According to the latest report by International Agency for Research on Cancer, 19.3 million
new cancer cases and 10 million cancer deaths were globally reported in 2020. Early …
new cancer cases and 10 million cancer deaths were globally reported in 2020. Early …